Colorectal cancer

Figure 8.9

Incidence and mortality rates^† for colorectal cancer, by sex, Canada — from 1992 to 2014

Download & Export
Figure
Data Table
- CSV
- Excel
- Json
- XML

^† Age-standardized to 2011 Canadian population.

QC: Cancer incidence data not available for 2011, 2012 and 2013 diagnosis years. The 2010 Quebec data have been copied forward into 2011, 2012 and 2013.

Data source: Statistics Canada, Vital Statistics Death Database, Canadian Cancer Registry (CANSIM).

Data Table

Year	Measure	Sex	Age-standardized incidence rate (per 100,000 population)	Lower bound of 95% confidence interval	Upper bound of 95% confidence interval
1992	Incidence	Female	58.7	57.3	60.1
1992	Incidence	Male	85.6	83.6	87.5
1992	Mortality	Female	28.2	27.3	29.2
1992	Mortality	Male	43.1	41.6	44.5
1993	Incidence	Female	58.7	57.3	60.1
1993	Incidence	Male	82.0	80.1	83.9
1993	Mortality	Female	28.2	27.3	29.2
1993	Mortality	Male	40.9	39.5	42.3
1994	Incidence	Female	57.6	56.2	58.9
1994	Incidence	Male	83.2	81.4	85.1
1994	Mortality	Female	27.8	26.9	28.7
1994	Mortality	Male	41.8	40.4	43.2
1995	Incidence	Female	56.1	54.8	57.4
1995	Incidence	Male	81.3	79.5	83.2
1995	Mortality	Female	27.5	26.6	28.5
1995	Mortality	Male	41.5	40.1	42.8
1996	Incidence	Female	54.7	53.5	56.0
1996	Incidence	Male	79.7	77.9	81.5
1996	Mortality	Female	27.4	26.5	28.3
1996	Mortality	Male	40.6	39.2	41.9
1997	Incidence	Female	55.0	53.7	56.2
1997	Incidence	Male	79.6	77.8	81.4
1997	Mortality	Female	26.1	25.2	27.0
1997	Mortality	Male	39.5	38.2	40.8
1998	Incidence	Female	58.1	56.8	59.4
1998	Incidence	Male	82.6	80.8	84.3
1998	Mortality	Female	27.0	26.2	27.9
1998	Mortality	Male	40.0	38.7	41.3
1999	Incidence	Female	56.9	55.6	58.1
1999	Incidence	Male	83.8	82.0	85.5
1999	Mortality	Female	26.1	25.3	27.0
1999	Mortality	Male	39.3	38.0	40.6
2000	Incidence	Female	58.3	57.0	59.5
2000	Incidence	Male	85.9	84.1	87.7
2000	Mortality	Female	25.4	24.6	26.2
2000	Mortality	Male	39.3	38.0	40.5
2001	Incidence	Female	57.3	56.1	58.6
2001	Incidence	Male	84.8	83.1	86.5
2001	Mortality	Female	24.9	24.1	25.7
2001	Mortality	Male	37.4	36.2	38.6
2002	Incidence	Female	56.7	55.5	57.9
2002	Incidence	Male	83.7	82.0	85.4
2002	Mortality	Female	24.6	23.8	25.4
2002	Mortality	Male	38.2	37.0	39.4
2003	Incidence	Female	55.7	54.6	56.9
2003	Incidence	Male	81.0	79.3	82.6
2003	Mortality	Female	23.8	23.1	24.6
2003	Mortality	Male	36.8	35.6	37.9
2004	Incidence	Female	56.3	55.1	57.5
2004	Incidence	Male	82.6	81.0	84.3
2004	Mortality	Female	24.1	23.3	24.9
2004	Mortality	Male	37.1	35.9	38.2
2005	Incidence	Female	56.0	54.8	57.1
2005	Incidence	Male	82.4	80.8	84.0
2005	Mortality	Female	23.5	22.8	24.3
2005	Mortality	Male	36.6	35.5	37.7
2006	Incidence	Female	54.4	53.3	55.5
2006	Incidence	Male	81.4	79.8	82.9
2006	Mortality	Female	22.0	21.3	22.7
2006	Mortality	Male	34.6	33.5	35.6
2007	Incidence	Female	55.0	53.9	56.1
2007	Incidence	Male	81.7	80.2	83.2
2007	Mortality	Female	22.9	22.2	23.6
2007	Mortality	Male	33.9	32.9	35.0
2008	Incidence	Female	54.5	53.4	55.6
2008	Incidence	Male	82.1	80.6	83.7
2008	Mortality	Female	22.1	21.4	22.8
2008	Mortality	Male	34.2	33.2	35.2
2009	Incidence	Female	54.0	52.9	55.1
2009	Incidence	Male	79.9	78.5	81.4
2009	Mortality	Female	21.2	20.5	21.9
2009	Mortality	Male	32.7	31.7	33.7
2010	Incidence	Female	53.2	52.2	54.3
2010	Incidence	Male	75.6	74.2	77.0
2010	Mortality	Female	20.9	20.2	21.5
2010	Mortality	Male	31.5	30.6	32.4
2011	Incidence	Female	52.7	51.6	53.7
2011	Incidence	Male	76.4	75.0	77.8
2011	Mortality	Female	21.0	20.4	21.7
2011	Mortality	Male	31.7	30.8	32.7
2012	Incidence	Female	52.6	51.5	53.6
2012	Incidence	Male	74.6	73.2	75.9
2012	Mortality	Female	19.9	19.3	20.6
2012	Mortality	Male	30.6	29.8	31.5
2013	Incidence	Female	52.0	50.9	53.0
2013	Incidence	Male	75.5	74.1	76.8
2013	Mortality	Female	20.2	19.6	20.9
2013	Mortality	Male	29.9	29.1	30.8
2014	Mortality	Female	20.0	19.4	20.6
2014	Mortality	Male	29.6	28.8	30.5

+ Expand Table

Figure 8.12

Incidence rates for colorectal cancer, by stage at diagnosis and province, age-standardized to the 2011 Canadian population — 2015 diagnosis year

Download & Export
Figure
Data Table
- CSV
- Excel
- Json
- XML

"– " Data not available.

Data source: Provincial cancer agencies and programs.

Data Table

Jurisdiction	Stage at Diagnosis	Age-standardized incidence (rate per 100,000 women)
BC	Stage I	16.8
BC	Stage II	16.2
BC	Stage III	21.4
BC	Stage IV	12.8
AB	Stage I	19
AB	Stage II	17.5
AB	Stage III	19
AB	Stage IV	14.4
SK	Stage I	23.2
SK	Stage II	19.2
SK	Stage III	23.2
SK	Stage IV	20
MB	Stage I	16.4
MB	Stage II	19.9
MB	Stage III	25.1
MB	Stage IV	16.2
ON	Stage I	16
ON	Stage II	16.4
ON	Stage III	18.9
ON	Stage IV	11.5
QC	Stage I	–
QC	Stage II	–
QC	Stage III	–
QC	Stage IV	–
NB	Stage I	16
NB	Stage II	20
NB	Stage III	21
NB	Stage IV	16
NS	Stage I	21.8
NS	Stage II	20.4
NS	Stage III	22.4
NS	Stage IV	20.2
PE	Stage I	16.8
PE	Stage II	20.5
PE	Stage III	32.2
PE	Stage IV	12.1
NL	Stage I	26.4
NL	Stage II	34.2
NL	Stage III	32.5
NL	Stage IV	20.8
YT	Stage I	–
YT	Stage II	–
YT	Stage III	–
YT	Stage IV	–
NT	Stage I	–
NT	Stage II	–
NT	Stage III	–
NT	Stage IV	–
NU	Stage I	–
NU	Stage II	–
NU	Stage III	–
NU	Stage IV	–

+ Expand Table

"– " Data not available.

Data source: Provincial cancer agencies and programs.

Data specifications
Data specifications
Cancer deaths

Definition: Age-standardized mortality rates per 100,000 population died from the specified cancer sites

Rationale for measurement: Data and metrics regarding age-standardized mortality rates are needed to provide an accurate measure of the burden of disease across Canada.

Measurement timeframe: Years 1992 to 2014

Denominator: Canadian population estimates by year, sex and age group

Numerator: Number of deaths in the measure timeframe from the specified cancers

Exclusion criteria: For breast cancer, males were excluded

Data availability: All provinces and territories

Stratification:

By cancer site: prostate, lung, breast (female), colorectal

By sex if applicable

By year

Data sources: Statistics Canada, Vital Statistics Death Database

Data retrieval date: December 2017

Variables details:

Up to the year 1999, the cause of deaths from invasive cancer sites/types were defined in ICD-9:

Prostate: 185

Lung: 162

Breast (female): 174

Colorectal: 153-154

After the year 1999, the cause of deaths from invasive cancer sites/types were defined in ICD-10:

Prostate: C61.9

Lung: C34

Breast: C50

Colorectal: C18, C19.9, C20.9, C26.0

Notes from jurisdictions: Not applicable

Methodology notes:

Data presented were jurisdictions combined for ages 0+.

The cause of death from cancer sites/types were classified by World Health Organization, International Classification of Diseases (ICD). Up to the year 1999, the Ninth Edition (ICD-9) was used. After the year 1999, the Tenth Edition (ICD-10) was used.

Mortality rates were age standardized to the Canadian 2011 population using direct method.

Changes to definition compared to previous years: Not applicable

Cancer incidence

Definition: Age-standardized incidence rates per 100,000 population diagnosed for the specified cancer sites

Rationale for measurement: Data and metrics regarding age-standardized incidence rates and trends are needed to provide an accurate measure of the burden of disease across Canada.

Measurement timeframe: Years 1992 to 2013

Denominator: Canadian population estimates by year, sex and age group

Numerator: Number of new invasive cases for the specified cancers diagnosed in the measure timeframe

Exclusion criteria: For breast cancer, males were excluded

Data availability: Data were aggregated at national level:

All provinces and territories, except QC which 2010 data have been copied forward to 2011, 2012 and 2013.

Stratification: Data were aggregated at national level:

By cancer site: prostate, lung, breast (female), colorectal

By sex if applicable

By year

Data source: Statistics Canada, Canadian Cancer Registry (CANSIM table 103-0554

Data retrieval date: October 2017

Variables details: The cancer sites/types were defined in ICD-O3 with behavior code 3 (invasive):

Prostate: 9

Lung: C34

Breast: C50

Colorectal: C18, C19.9, C20.9, C26.0

Cancer cases with histology types 9590-9992 (leukemia, lymphoma and multiple myeloma), 9050-9055 (mesothelioma) and 9140 (Kaposi sarcoma) are excluded.

Notes from jurisdictions: Not applicable

Methodology notes:

Data presented were jurisdictions combined for ages 0+.

The cancer incidence sites/types were classified by World Health Organization, International Classification of Diseases for Oncology, Third Edition (ICD- O-3). The International Agency for Research on Cancer (IARC) rules were used for determining multiple primaries sites.

QC incidence data were not available for 2011 onward, incidence cases and population data in 2010 were copied forward to 2011, 2012 and 2013

Incidence rates were age standardized to the Canadian 2011 population using direct method.

Changes to definition compared to previous years: Not applicable
Related indicators

Related Indicators

Colorectal cancer screening

Participation rate in colorectal cancer screening programs in a 30-month period (%), by jurisdiction – 2013-14 screening years combined

View this indicator

Colorectal cancer diagnosis wait times

Median and 90^th percentile wait times from abnormal fecal test result to follow-up colonoscopy, by jurisdiction – 2015 screening year

Show Target - Figure 3.3

View this indicator

Removal and examination of 12 or more lymph nodes in colon resections

Percentage of colon resections with 12 or more lymph nodes removed and examined, by jurisdiction — 2011 to 2014 diagnosis years

Show Target - Figure 4.1Show Confidence Intervals - Figure 4.1

View this indicator

Post-operative chemotherapy for stage III colon cancer patients

Percentage of Stage III colon cancer patients receiving chemotherapy following surgical resection, by age group — from 2009 to 2012 diagnosis years

View this indicator

Geographic variation in colorectal cancer risk

Geographic variation in modifiable risk factors and colorectal cancer incidence – latest reporting years

^† Composites were created by summation of jurisdictional cancer risk factors (overweight and obesity, physical inactivity, excessive alcohol consumption and low fruit and vegetables consumption) and their respective prevalence. Derived values were then divided into tertiles to generate groups of lower, middle and higher risk.

^‡ For incidence rates for territories, years 2012 to 2014 were combined.

^E Interpret with caution due to large variability in the estimate.

QC: cancer incidence data are not available for diagnosis years after 2010. The 2010 Quebec incidence and population data have been copied forward to 2014 for the calculation.

Data sources: Statistics Canada: Canadian Community Health Survey, Canadian Cancer Registry.

View this indicator

Index

Charts and Tables

Figure 8.9

Incidence and mortality rates^† for colorectal cancer, by sex, Canada — from 1992 to 2014

Figure

Data Table

Data Table

Figure 8.12

Incidence rates for colorectal cancer, by stage at diagnosis and province, age-standardized to the 2011 Canadian population — 2015 diagnosis year

Figure

Data Table

Data Table

Data specifications

Cancer deaths

Cancer incidence

Other related sites:

Questions about cancer?

Index

Colorectal cancer

Charts and Tables

Figure 8.9

Incidence and mortality rates† for colorectal cancer, by sex, Canada — from 1992 to 2014

Figure

Data Table

Data Table

Figure 8.12

Incidence rates for colorectal cancer, by stage at diagnosis and province, age-standardized to the 2011 Canadian population — 2015 diagnosis year

Figure

Data Table

Data Table

Data specifications

Cancer deaths

Cancer incidence

Related Indicators

Other related sites:

Questions about cancer?

Incidence and mortality rates^† for colorectal cancer, by sex, Canada — from 1992 to 2014